Building a reliable stained smear quality assurance program for TB
A stained smear quality assurance program helps tuberculosis laboratories produce microscopy results that are accurate, reproducible, timely, and safe. Although molecular tests have expanded TB diagnostic capacity, smear microscopy remains important for finding infectious pulmonary disease, monitoring treatment in some settings, and supporting services where advanced equipment is limited.
Quality assurance covers the complete testing pathway. It begins with selecting and receiving suitable sputum, continues through smear preparation, staining, examination, interpretation, and reporting, and ends with reviewing results and correcting weaknesses. Focusing only on the microscope or staining bench leaves important sources of error unmanaged.
The program should be practical for the laboratory’s workload, staff, equipment, and biosafety conditions. A documented system with clear responsibilities allows supervisors to detect problems early rather than discovering them through an unexpected proficiency-testing failure or a clinical complaint.
Define the program’s purpose and scope
Start by writing a short quality statement that explains what the smear service must deliver. It should specify that patient specimens are processed safely, smears are stained consistently, slides are examined according to an approved method, results are reported within the expected turnaround time, and errors are investigated.
The scope should include both Ziehl-Neelsen or Kinyoun staining and fluorescence microscopy if the laboratory uses them. It should also cover specimen collection instructions, transport, accessioning, rejection criteria, slide labeling, preparation of smears, staining reagents, microscopy, result verification, reporting, referral, waste management, and record retention.
Assign responsibility at each point. A bench technologist may perform daily controls, a section supervisor may review logs and investigate deviations, and the laboratory manager may authorize corrective actions and monitor quality indicators. Staff should know who can stop testing when a reagent, microscope, or safety control is unsuitable.
Use the twelve Quality Systems Essentials as a practical framework for organizing the work. The GLI Quality Tool’s user instructions can help teams navigate the roadmap, adapt checklists, and connect smear microscopy activities with broader laboratory management practices.
Standardize specimen and smear preparation
A dependable result begins with an adequate specimen. Written instructions should describe the preferred specimen type, volume, container, collection location, labeling requirements, transport conditions, and maximum acceptable delay before processing. Staff receiving specimens should record whether the container is intact, the label matches the request, and the sample is sufficient for testing.
Rejection criteria must be specific and consistently applied. Examples include an unlabeled container, a leaking container, an unsuitable specimen, or a mismatch between the request form and the sample. When possible, document the reason for rejection and communicate promptly with the responsible clinical unit. If a specimen cannot be recollected, the laboratory should follow an approved process for documenting the limitation.
The smear procedure should define the size and thickness of the smear, drying position, fixation method, and acceptable slide type. A smear that is too thick may retain stain and obscure bacilli, while one that is too thin may contain too little material. The procedure should also address how to avoid cross-contamination between specimens, including separate applicators or carefully controlled work practices.
Use unique identifiers on every slide and match them with the laboratory register. A second person or an electronic check can verify labels before staining. These basic controls prevent clerical errors from being mistaken for staining or microscopy failures.
Control stains, microscopy, and interpretation
Each staining method needs a current standard operating procedure with reagent concentrations, preparation instructions, storage conditions, expiration dates, staining times, rinsing steps, and maintenance requirements. Prepared reagents should carry the preparation date, expiry date, lot number, and initials of the person responsible.
Run known control material at a defined frequency and whenever a new stain batch is prepared or a major problem is suspected. A positive control should demonstrate that acid-fast bacilli retain the expected color and appearance. A negative control should show a clean background without acid-fast structures that could be confused with bacilli. Controls must be examined before patient results are released when the procedure requires it.
Microscopes need a scheduled maintenance program. Daily checks can include cleanliness of lenses, illumination, mechanical movement, oil removal, and availability of the correct objective. Periodic servicing should address alignment, electrical safety, lamp or light-source performance, and replacement of worn components. Fluorescence systems require additional attention to filters, light intensity, and dark-room conditions.
Interpretation rules should define the number of fields examined, reporting categories, scanty results, and the process for reviewing slides with unusual debris or artifacts. A standardized reporting scale reduces variation among readers. When a result is unexpected or clinically inconsistent, a designated reviewer should examine the slide and verify the report before release where feasible.
Measure performance through internal and external checks
Internal quality control is the routine monitoring performed within the laboratory. Supervisors can recheck a defined proportion of negative smears and all scanty or otherwise critical results, using a risk-based approach. Rechecking should be blind when possible so that the second reader is not influenced by the original interpretation.
The laboratory should also participate in an external quality assessment activity. Options may include panel testing, blinded rechecking by a reference laboratory, or an onsite assessment. The chosen approach should reflect national guidance and available resources. EQA is most useful when results are reviewed with staff and converted into specific corrective actions.
Track indicators monthly or quarterly rather than waiting for an annual review. Useful measures include the proportion of rejected specimens, invalid or unreadable smears, staining-control failures, turnaround time, discordant recheck results, false-positive and false-negative findings, EQA performance, and the percentage of staff who remain current in competency assessment.
| Quality area | Example measure | Review trigger | Possible response |
|---|---|---|---|
| Specimen quality | Rejected or inadequate specimens | Rate rises above the local baseline | Retrain collectors and review transport |
| Staining | Failed or weak control slides | Any control failure before reporting | Quarantine reagents and repeat staining |
| Reading accuracy | Discordant recheck results | Repeated or clinically significant discordance | Supervised rereading and competency review |
| Timeliness | Results reported within target time | Performance falls for two review periods | Examine workload, staffing, and workflow |
| Equipment | Missed maintenance or microscope faults | Scheduled task is overdue or performance changes | Service equipment and document verification |
| EQA | Unsatisfactory panel or rechecking result | Any unacceptable cycle | Perform root-cause analysis and follow-up |
Build competency and assessment into routine work
Initial training should combine theory, demonstration, supervised practice, and an assessment using representative slides. Staff need to show competence in biosafety, smear preparation, staining, microscope use, recognition of acid-fast bacilli, grading, recording, and result reporting. A signed competency record should state the method assessed, date, assessor, findings, and authorization status.
Competency is not permanent. Reassess personnel at a defined interval and after extended absence, introduction of a new method, major equipment change, repeated errors, or an unsatisfactory EQA outcome. Use a mixture of direct observation, slide challenges, record review, and discussion of problem cases.
Maintain a teaching and challenge-slide collection that represents positive, negative, scanty, artifact-containing, and difficult specimens. Slides should be verified, stored securely, and accompanied by an answer key accessible only to the assessor. Digital images can supplement glass slides, but they should not replace practical assessment when staff routinely examine conventional smears.
When performance is weak, respond with targeted support rather than assigning blame. Retraining might address focusing technique, field counting, recognition of artifacts, or interpretation of the reporting scale. The staff member should be reassessed before returning to independent testing, with temporary review of their results if patient safety may be affected.
Document errors and drive corrective action
Every deviation should be recorded in a way that supports analysis. The record should include the date, specimen or batch identifier where appropriate, description of the problem, immediate containment, person notified, probable cause, corrective action, responsible person, deadline, and evidence that the action worked.
Examples include a failed positive control, a mislabeled slide, contaminated staining equipment, an unreadable smear, a delayed report, or a discrepancy found during rechecking. Immediate containment may involve stopping result release, repeating the control, restaining affected slides, notifying a clinician, or reviewing specimens processed in the same batch.
Root-cause analysis should examine systems, not just individual behavior. Consider reagent preparation, storage temperature, workload, supervision, unclear instructions, equipment condition, environmental lighting, supply interruptions, and communication with specimen collection sites. A simple “five whys” review is often sufficient for recurring problems.
The final phase of the GLI roadmap provides useful support for continual improvement guidance, including reviewing evidence, addressing gaps, and sustaining gains. Use audit findings, indicator trends, EQA results, staff feedback, and patient-related incidents to set measurable improvement objectives.
Put the program into daily practice
A quality assurance plan becomes effective when its requirements fit the bench routine. Keep current procedures at the point of use, remove obsolete copies, and ensure that logs are easy to complete. Supervisors should review records on a predictable schedule and discuss trends during brief team meetings.
A small laboratory can begin with a controlled staining process, documented microscopy criteria, a reagent log, daily equipment checks, periodic blinded rechecking, and competency records. As capacity grows, it can add more detailed indicators, electronic tracking, expanded EQA participation, and structured audits.
Practical actions for implementation include:
- Map every step from specimen collection through result reporting and assign an accountable person.
- Approve procedures for smear preparation, staining, microscopy, reporting, safety, and error management.
- Establish positive and negative controls, reagent logs, microscope maintenance records, and slide rechecking rules.
- Review quality indicators at least monthly and investigate trends before they become failures.
- Record corrective actions with deadlines and verify that each intervention produced sustained improvement.
A well-designed stained smear quality assurance program protects patients, supports reliable surveillance data, and strengthens confidence in laboratory findings. Begin by documenting the current workflow, identifying its highest-risk steps, and introducing controls that staff can perform consistently. Then use measured results and regular review to expand the system until quality is part of every smear, every reading, and every report.